natgillin/translations-raw huggingface dataset:
Suspension for injection 5 x (1 x 10 ml) This is a multipack and not for sale of individual vials
5 x (1 x 10 ml) To pakiranje z več vialami ni namenjeno za izdajanje posameznih vial.
113 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
113 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 30 vial 100 IU/ ml
Actraphane 30 viala 40 i. e. / ml
115 PARTICULARS TO APPEAR ON THE PACKAGING
115 PODATKI NA NALEPKI ZUNANJEGA OVOJA SKUPNIH PAKIRANJ, OVITIH V PROSOJNO FOLIJO
OUTHER WRAPPER LABEL ON MULTIPACKS
NALEPKA ZUNANJEGA OVOJA PAKIRANJA Z VEČ VIALAMI
117 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
117 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 10 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Actraphane 10 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
1 ml suspension contains 100 IU (3.5 mg) of insulin human (rDNA) (10% as soluble insulin and 90% as isophane insulin).
(3, 5 mg) humanega insulina (rDNA) (10% topnega insulina in 90% insulina izofan),
Suspension for injection 1 x 3 ml 5 x 3 ml 10 x 3 ml
1 x 3 ml 5 x 3 ml 10 x 3 ml
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Actraphane 10 Penfill is for use by one person only
Actraphane 10 Penfill je namenjen uporabi ene same osebe.
Store in a refrigerator (2°C - 8°C) Do not freeze Keep the cartridge in the outer carton in order to protect from light During use: do not refrigerate or store above 30°C
Med uporabo: ne shranjujte v hladilniku ali pri temperaturi nad 30 °C!
119 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
119 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
PENFILL LABEL
NALEPKA PENFILL
Actraphane 10 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 10 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
120 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
120 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 20 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Actraphane 20 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
1 ml suspension contains 100 IU (3.5 mg) of insulin human (rDNA) (20% as soluble insulin and 80% as isophane insulin).
(3, 5 mg) humanega insulina (rDNA) (20% topnega insulina in 80% insulina izofan),
METHOD AND ROUTE OF ADMINISTRATION
POSTOPEK IN POT( I) UPORABE ZDRAVILA
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Actraphane 20 Penfill is for use by one person only
Actraphane 20 Penfill je namenjen uporabi ene same osebe.
122 229MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
122 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 20 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 20 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
123 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
123 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 30 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA),
Actraphane 30 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Actraphane 30 Penfill is for use by one person only
Actraphane 30 Penfill je namenjen uporabi ene same osebe.
125 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
125 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 30 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 30 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
126 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
126 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 40 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Actraphane 40 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
1 ml suspension contains 100 IU (3.5 mg) of insulin human (rDNA) (40% as soluble insulin and 60% as isophane insulin).
(3, 5 mg) humanega insulina (rDNA) (40% topnega insulina in 60% insulina izofan),
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Actraphane 40 Penfill is for use by one person only
Actraphane 40 Penfill je namenjen uporabi ene same osebe.
128 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
128 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 40 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 40 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
129 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
129 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 50 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Actraphane 50 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
1 ml suspension contains 100 IU (3.5 mg) of insulin human (rDNA) (50% as soluble insulin and 50% as isophane insulin).
(3, 5 mg) humanega insulina (rDNA) (50% topnega insulina in 50% insulina izofan),
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Actraphane 50 Penfill is for use by one person only
Actraphane 50 Penfill je namenjen uporabi ene same osebe.
131 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
131 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 50 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 50 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
132 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
132 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 10 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 10 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Suspension for injection 5 x 3 ml 10 x 3 ml
5 x 3 ml 10 x 3 ml
Subcutaneous use Actraphane 10 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Actraphane 10 NovoLet is for use by one person only
Actraphane 10 NovoLet je namenjen uporabi ene same osebe.
Store in a refrigerator (2°C - 8°C) Do not freeze Protect from light During use: do not refrigerate or store above 30°C
Shranjujte zaščiteno pred svetlobo!
134 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
134 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
NOVOLET LABEL
NALEPKA NOVOLET
Actraphane 10 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 10 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
135 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
135 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 20 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 20 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Actraphane 20 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Actraphane 20 NovoLet is for use by one person only
Actraphane 20 NovoLet je namenjen uporabi ene same osebe.
137 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
137 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 20 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 20 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
138 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
138 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 30 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 30 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Actraphane 30 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Actraphane 30 NovoLet is for use by one person only
Actraphane 30 NovoLet je namenjen uporabi ene same osebe.
140 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
140 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 30 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 30 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
141 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
141 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 40 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 40 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Actraphane 40 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Actraphane 40 NovoLet is for use by one person only
Actraphane 40 NovoLet je namenjen uporabi ene same osebe.
143 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
143 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 40 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 40 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
144 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
144 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 50 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 50 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Actraphane 50 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Actraphane 50 NovoLet is for use by one person only
Actraphane 50 NovoLet je namenjen uporabi ene same osebe.
146 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
146 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Actraphane 50 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 50 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
147 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
147 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 30 InnoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 30 InnoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Actraphane 30 InnoLet is designed to be used with NovoFine S needles Resuspend according to instructions Read the package leaflet before use Actraphane 30 InnoLet is for use by one person only
Actraphane 30 InnoLet je namenjen uporabi ene same osebe.
149 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
149 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
INNOLET LABEL
NALEPKA INNOLET
Actraphane 30 InnoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 30 InnoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
150 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
150 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Actraphane 30 FlexPen 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Actraphane 30 FlexPen 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm Needles are not included Resuspend according to instructions Read the package leaflet before use Actraphane 30 FlexPen is for use by one person only
Actraphane 30 FlexPen je namenjen uporabi ene same osebe.
152 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
152 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
FLEXPEN LABEL
NALEPKA FLEXPEN
Actraphane 30 FlexPen 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Actraphane 30 FlexPen 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
154 PACKAGE LEAFLET:
154 NAVODILO ZA UPORABO
Actraphane 30 40 IU/ ml suspension for injection in a vial Insulin human (rDNA)
Actraphane 30 40i. e. / ml suspenzija za injiciranje v viali humani insulin (rDNA)
Read all of this leaflet carefully before you start using your insulin. – Keep this leaflet.
Preden začnete uporabljati vaš insulin natančno preberite navodilo! – Navodilo shranite.
Do not pass it on to others.
Morda ga boste želeli ponovno prebrati. – Če imate dodatna vprašanja, se posvetujte z zdravnikom, diabetološko sestro ali s farmacevtom. – Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist.
Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim. – Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen tem navodilu, obvestite svojega zdravnika, diabetološko sestro ali farmacevta.
WHAT ACTRAPHANE IS AND WHAT IT IS USED FOR
KAJ JE ACTRAPHANE IN ZA KAJ SE UPORABLJA
Actraphane is human insulin to treat diabetes.
Actraphane je humani insulin za zdravljenje diabetesa.
Actraphane is a mixture of fast-acting insulin and long-acting insulin.
Actraphane je mešanica hitrodelujočega in dolgodelujočega insulina.
This means that it will start to lower your blood sugar about half an hour after you take it, and the effect will last for approximately 24 hours.
To pomeni, da začne sladkor v krvi zniževati približno pol ure po uporabi, njegov učinek pa traja približno 24 ur.
BEFORE YOU USE ACTRAPHANE
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ACTRAPHANE
► If you are allergic (hypersensitive) to this insulin product, metacresol or any of the other ingredients (see 7 Further information).
Ne uporabljajte zdravila Actraphane, če ste alergični na (preobčutljivi za) to insulinsko zdravilo, metakrezol ali kakšno drugo ► sestavino tega zdravila (glejte poglavje 7, Dodatne informacije).
Look out for the signs of allergy in 5 Possible side effects ► If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is a symptom of low blood sugar).
Možni neželeni učinki; čutite, da se pojavlja hipa (hipa je okrajšava za hipoglikemično reakcijo in pomeni simptome ► nizkega sladkorja v krvi).
Take special care with Actraphane
Ukrepanje v nujnih primerih.
► If you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands ► If you are drinking alcohol: watch for signs of a hypo and never drink alcohol on an empty stomach ► If you are exercising more than usual or if you want to change your usual diet ► If you are ill: carry on taking your insulin ► If you are going abroad: travelling over time zones may affect your insulin needs and the timing of your injections.
Pri uporabi zdravila Actraphane bodite posebno pozorni, če imate težave z ledvicami, jetri, z nadledvično žlezo, hipofizo ali ščitnico; ► če pijete alkohol: pazite na znake hipe in alkohola nikdar ne pijte na prazen želodec; ► če ste telesno bolj dejavni kot ponavadi ali želite spremeniti svojo običajno prehrano; ► če ste bolni: insulin uporabljajte še naprej; ► če potujete v tujino: potovanje med različnimi časovnimi pasovi lahko vpliva na potrebe po ► insulinu in časovni razpored injekcij.
Many medicines affect the way glucose works in your body and they may influence your insulin dose.
Uporaba drugih zdravil Številna zdravila vplivajo na delovanje glukoze v telesu in lahko tako vplivajo na vaš odmerek insulina.
Talk to your doctor or pharmacist if you take or have recently taken any other medicines, even those not prescribed.
Posvetujte se z zdravnikom ali s farmacevtom, če jemljete ali ste pred kratkim jemali katero koli drugo zdravilo, tudi če ste ga dobili brez recepta.
Your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (MAOI); beta-blockers; ACE-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; beta- sympathomimetics; growth hormone; danazol; octreotide or lanreotide.
Vaša potreba po insulinu se lahko spremeni, če uporabljate tudi: peroralna antidiabetična zdravila, zaviralce monoaminooksidaze (MAOI), zaviralce receptorjev beta, zaviralce ACE, acetilsalicilno kislino, anabolne steroide, sulfonamide, oralne kontraceptive, tiazide, glukokortikoide, zdravljenje s ščitničnimi hormoni, beta- simpatikomimetike, rastni hormon, danazol, oktreotid in lanreotid.
Pregnancy and breast-feeding
Nosečnost in dojenje Če ste noseči, nameravate zanositi ali če dojite: za nasvet prosite svojega zdravnika.
If you are pregnant, planning a pregnancy or breast-feeding: please contact your doctor for advice.
Nikdar ne vozite in ne uporabljajte strojev, če čutite, da se pojavlja
155 Driving and using machines
155 hipa.
Discuss with your doctor whether you can drive or use machines at all, if you have a lot of hypos or if you find it hard to recognise hypos.
Z zdravnikom se posvetujte, ali lahko sploh vozite ali upravljate s stroji, če doživljate veliko hip ali hipe težko prepoznate.
HOW TO USE ACTRAPHANE
KAKO UPORABLJATI ZDRAVILO ACTRAPHANE
Follow their advice carefully.
Natančno upoštevajte njihova navodila.
Eat a meal or snack containing carbohydrates within 30 minutes of the injection.
V 30 minutah po injekciji pojejte obrok ali prigrizek, ki vsebuje ogljikove hidrate.
It is recommended that you measure your blood glucose regularly.
Priporočljivo je, da si redno merite glukozo v krvi.
► Check the label to make sure it is the right type of insulin ► Disinfect the rubber membrane with a medicinal swab.
Preden uporabite zdravilo Actraphane Prepričajte se, da imate pravo vrsto insulina. ► Dezinficirajte gumijasto membrano z medicinskim zložencem. ►
► In insulin infusion pumps ► If the protective cap is loose or missing.
Ne uporabljajte zdravila Actraphane, v insulinskih infuzijskih črpalkah; ► če zaščitna zaporka ni trdno pričvrščena ali je sploh ni.
Each vial has a protective, tamper-proof plastic cap.
Vsaka viala ima zaščitno, varovalno ► plastično zaporko.
If it isn’ t in perfect condition when you get the vial, return the vial to your supplier ► If it hasn’ t been stored correctly or been frozen (see 6 How to store Actraphane) ► If it’ s not uniformly white and cloudy when it’ s resuspended.
Če zaporka tedaj, ko vialo dobite, ni v povsem brezhibnem stanju, vialo vrnite dobavitelju; če ni bilo shranjeno pravilno ali je zamrznilo (glejte poglavje 6.
How to use this insulin
Shranjevanje zdravila ► Actraphane); če po resuspendiranju ni enakomerno belo in motno. ►
Actraphane is for injection under the skin (subcutaneously).
Uporaba tega insulina Zdravilo Actraphane je namenjeno injiciranju pod kožo (subkutani uporabi).
Never inject your insulin directly into a vein or muscle.
Insulina si nikoli ne injicirajte neposredno v veno ali mišico.
Always vary the sites you inject, to avoid lumps (see 5 Possible side effects).
Mesta injiciranj vedno menjajte, da boste preprečili nastanek zatrdlin (glejte poglavje 5.
Your insulin will work more quickly if you inject it around the waist.
Insulin bo deloval hitreje, če ga injicirate v predelu trebuha.
1.
Tik preden si injicirate ta insulin 1.
Roll the vial between your hands until the liquid is uniformly white and cloudy.
Vrtite vialo med dlanmi, dokler tekočina ni enakomerno bela in motna.
Inject straight away.
9.
Inject the insulin
Takoj injicirajte.
► Inject the insulin under the skin.
Injicirajte insulin Insulin injicirajte pod kožo.
Use the injection technique advised by your doctor or diabetes nurse
Za injiciranje uporabite postopek, ki vam ga je svetoval zdravnik ► ali diabetološka sestra.
156 ► Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered.
Igla mora ostati pod kožo vsaj 6 sekund, da je zanesljivo injiciran celotni odmerek. ►
WHAT TO DO IN AN EMERGENCY
UKREPANJE V NUJNIH PRIMERIH
A hypo means your blood sugar level is too low.
Če doživite hipo Hipa pomeni, da imate prenizek sladkor v krvi.
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Opozorilni znaki hipe se lahko pojavijo nenadoma in lahko obsegajo: hladno znojenje; hladno in bledo kožo;, glavobol; hitro bitje srca; občutek slabosti; hudo lakoto, prehodne spremembe vida; zaspanost; nenavadno utrujenost in šibkost; živčnost ali tresenje; občutek tesnobe; občutek zmedenosti; težave s koncentracijo.
If you get any of these signs, eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest.
Če se pojavi kateri od teh znakov, zaužijte tablete glukoze ali prigrizek, ki vsebuje veliko sladkorja (bonbone, piškote, sadni sok), in nato počivajte.
Don’ t take any insulin if you feel a hypo coming on.
Če čutite, da se pojavlja hipa, si ne dajajte insulina.
Tell your relatives, friends and close colleagues that if you pass out (become unconscious), they must: turn you on your side and seek medical advice straight away.
Svojim sorodnikom, prijateljem in bližnjim sodelavcem povejte, da vas morajo v primeru, da se onesvestite (izgubite zavest), položiti na bok in nemudoma poiskati zdravniško pomoč.
They must not give you any food or drink as it could choke you. ► If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death ► If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor.
Če doživite hipo, zaradi katere se onesvestite, ali doživljate veliko hip, se posvetujte z ► zdravnikom.
You may recover more quickly from unconsciousness with an injection of the hormone glucagon by someone who knows how to use it.
Uporaba glukagona Iz nezavesti se boste morda zbudili prej, če dobite injekcijo hormona glukagona; dati jo mora oseba, ki ga zna uporabljati.
If you are given glucagon you will need glucose or a sugary snack as soon as you are conscious.
Če dobite glukagon, boste potrebovali glukozo ali sladek prigrizek, takoj ko se zaveste.
Seek medical advice after an injection of glucagon; you need to find the reason for your hypo to avoid getting more.
Po injekciji glukagona poiščite zdravniško pomoč: ugotoviti morate razlog za hipo, da jih ne boste doživeli še več.
You get a hypo if your blood sugar gets too low.
Vzroki za hipe Hipa se pojavi, če se sladkor v krvi preveč zniža.